2024 21 CFR 329.100 – Postmarketing reporting of adverse drug events under section 760 of the Federal Food, Drug, and Cosmetic Act

2023 21 CFR 329.100 – Postmarketing reporting of adverse drug events under section 760 of the Federal Food, Drug, and Cosmetic Act

2022 21 CFR 329.100 – Postmarketing reporting of adverse drug events under section 760 of the Federal Food, Drug, and Cosmetic Act

2021 21 CFR 329.100 – Postmarketing reporting of adverse drug events under section 760 of the Federal Food, Drug, and Cosmetic Act

2020 21 CFR 329.100 – Postmarketing reporting of adverse drug events under section 760 of the Federal Food, Drug, and Cosmetic Act

2019 21 CFR 329.100 – Postmarketing reporting of adverse drug events under section 760 of the Federal Food, Drug, and Cosmetic Act

2016 21 CFR 329.100 – Postmarketing reporting of adverse drug events under section 760 of the Federal Food, Drug, and Cosmetic Act

2015 21 CFR 329.100 – Postmarketing reporting of adverse drug events under section 760 of the Federal Food, Drug, and Cosmetic Act